- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting mTOR in Acute Lymphoblastic Leukemia
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 2, Pages 190
Publisher
MDPI AG
Online
2019-02-22
DOI
10.3390/cells8020190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic CAR T cell therapies for leukemia - R1
- (2019) Waseem Qasim AMERICAN JOURNAL OF HEMATOLOGY
- Connecting chaperone-mediated autophagy dysfunction to cellular senescence
- (2018) Daniel Moreno-Blas et al. AGEING RESEARCH REVIEWS
- VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia
- (2018) Bahareh Toosi et al. BIOMEDICINE & PHARMACOTHERAPY
- Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex
- (2018) Anastasios Gkountakos et al. CARCINOGENESIS
- Drug discovery targeting the mTOR pathway
- (2018) Alberto M. Martelli et al. CLINICAL SCIENCE
- Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update
- (2018) Carolina Simioni et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine
- (2018) Xiaomo Wu et al. Journal of Proteomics
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia
- (2018) Andrew E. Place et al. PEDIATRIC BLOOD & CANCER
- Autophagy induced by cardamonin is associated with mTORC1 inhibition in SKOV3 cells
- (2018) Daohua Shi et al. Pharmacological Reports
- mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL
- (2018) Moran Gotesman et al. Oncotarget
- Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome–like acute B-cell lymphoblastic leukemia
- (2018) Qi Zhang et al. Oncotarget
- mTOR Pathways in Cancer and Autophagy
- (2018) Mathieu Paquette et al. Cancers
- New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update
- (2018) Adrián Montaño et al. Cancers
- mTOR Cross-Talk in Cancer and Potential for Combination Therapy
- (2018) Fabiana Conciatori et al. Cancers
- TFEB-driven endocytosis coordinates MTORC1 signaling and autophagy
- (2018) Israel C. Nnah et al. Autophagy
- Philadelphia-Like acute lymphoblastic leukemia: diagnostic dilemma and management perspectives
- (2018) Ahmed Kotb et al. EXPERIMENTAL HEMATOLOGY
- Biological Aspects of mTOR in Leukemia
- (2018) Simone Mirabilii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
- (2018) Andrea Ghelli Luserna Di Rorà et al. Journal of Hematology & Oncology
- Correction: p53 and metabolism: from mechanism to therapeutics
- (2018) Fernando M. Simabuco et al. Oncotarget
- Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
- (2018) Luca Bertamini et al. BMC CANCER
- Chimeric antigen receptors: unleashing a new age of anti-cancer therapy
- (2018) Yan Leyfman Cancer Cell International
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression
- (2018) Mio Harachi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- mTORC1 as the main gateway to autophagy
- (2017) Yoana Rabanal-Ruiz et al. Essays in Biochemistry
- Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
- (2017) Ariella Tvito et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- mTORC2 (Rictor) in Alzheimer’s Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons
- (2017) Han-Kyu Lee et al. JOURNAL OF ALZHEIMERS DISEASE
- PtdIns3P controls mTORC1 signaling through lysosomal positioning
- (2017) Zhi Hong et al. JOURNAL OF CELL BIOLOGY
- Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia
- (2017) Cecilia Evangelisti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
- (2017) Guoqing Wei et al. Journal of Hematology & Oncology
- Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis
- (2017) S J Welsh et al. LEUKEMIA
- The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
- (2017) T Girardi et al. LEUKEMIA
- Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cells
- (2017) Véronique Imbert et al. LEUKEMIA & LYMPHOMA
- Current approach to the treatment of chronic myeloid leukaemia
- (2017) Ivan Pasic et al. LEUKEMIA RESEARCH
- Metabolic gatekeeper function of B-lymphoid transcription factors
- (2017) Lai N. Chan et al. NATURE
- Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia
- (2017) Josep-Maria Ribera Expert Review of Hematology
- Overexpression of dominant-negative Ikaros 6 isoform is associated with resistance to TKIs in patients with Philadelphia chromosome positive acute lymphoblastic leukemia
- (2017) Changfeng Shao et al. Experimental and Therapeutic Medicine
- Acute lymphoblastic leukemia: a comprehensive review and 2017 update
- (2017) T Terwilliger et al. Blood Cancer Journal
- The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells
- (2017) Gabriele Stefanzl et al. Oncotarget
- Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia
- (2017) Guopan Yu et al. Oncotarget
- PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines
- (2017) Simona Ultimo et al. Oncotarget
- New Therapeutic Strategies in Acute Lymphocytic Leukemia
- (2017) Louise M. Man et al. Current Hematologic Malignancy Reports
- Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases
- (2017) Avileen Kaur et al. INFLAMMOPHARMACOLOGY
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Ibrutinib inhibits pre-BCR+B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK
- (2016) Ekaterina Kim et al. BLOOD
- Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
- (2016) Sarah K. Tasian et al. BLOOD
- 4EBP1/c-MYC/PUMA and NF- B/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells
- (2016) S. Yun et al. BLOOD
- Pharmacological properties of a novel and potent γ-secretase modulator as a therapeutic option for the treatment of Alzheimer’s disease
- (2016) Koji Murakami et al. BRAIN RESEARCH
- The therapeutic potential of mTOR inhibitors in breast cancer
- (2016) Linda S. Steelman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Targeting mTOR for the treatment of B cell malignancies
- (2016) Jong-Hoon Scott Lee et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Beating the Clock in T-cell Acute Lymphoblastic Leukemia
- (2016) William L. Carroll et al. CLINICAL CANCER RESEARCH
- Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia
- (2016) Yana Pikman et al. CLINICAL CANCER RESEARCH
- Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
- (2016) Zhipeng Zou et al. CURRENT CANCER DRUG TARGETS
- The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia
- (2016) R. D. Mendes et al. HAEMATOLOGICA
- mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation
- (2016) Hu Zeng et al. IMMUNITY
- mTORC signaling in hematopoiesis
- (2016) Xiaomin Wang et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Targeting the mTOR Pathway in Leukemia
- (2016) Shira Dinner et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
- (2016) Pei-Jie Shi et al. Journal of Hematology & Oncology
- Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism
- (2016) Terri N. Iwata et al. JOURNAL OF IMMUNOLOGY
- Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
- (2016) S Eldfors et al. LEUKEMIA
- Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC and can be targeted by SYK inhibition
- (2016) S Köhrer et al. LEUKEMIA
- ULK1/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy
- (2016) Terytty Yang Li et al. MOLECULAR CELL
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia
- (2016) Y Hu et al. ONCOGENE
- Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation
- (2016) Qiang Zhang et al. Journal of Molecular Cell Biology
- Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia
- (2016) Carolina Simioni et al. Oncotarget
- Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia
- (2016) Ayman A.M. Alameen et al. Oncotarget
- Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
- (2016) Zheng Ge et al. Oncotarget
- IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
- (2016) Yunlei Li et al. PLOS MEDICINE
- The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia
- (2016) R. D. Mendes et al. HAEMATOLOGICA
- Ph-like acute lymphoblastic leukemia
- (2016) T. H. Tran et al. Hematology-American Society of Hematology Education Program
- Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia
- (2015) Benedito A Carneiro et al. CANCER BIOLOGY & THERAPY
- mTORC1 signaling activates NRF1 to increase cellular proteasome levels
- (2015) Yinan Zhang et al. CELL CYCLE
- A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2015) N. Daver et al. CLINICAL CANCER RESEARCH
- Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235
- (2015) C. P. Hall et al. CLINICAL CANCER RESEARCH
- Mechanisms of resistance to BCR–ABL TKIs and the therapeutic strategies: A review
- (2015) Ke Yang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells
- (2015) Huibo Li et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Rewired Metabolism in Drug-resistant Leukemia Cells
- (2015) Claudia Stäubert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
- (2015) J Eswaran et al. LEUKEMIA
- Disruption of pre-B-cell receptor signaling jams the WNT/β-catenin pathway and induces cell death in B-cell acute lymphoblastic leukemia cell lines
- (2015) Nakhle S. Saba et al. LEUKEMIA RESEARCH
- Lysosomal mTORC2/PHLPP1/Akt Regulate Chaperone-Mediated Autophagy
- (2015) Esperanza Arias et al. MOLECULAR CELL
- Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A
- (2015) Pui-Mun Wong et al. Nature Communications
- PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
- (2015) P. Liu et al. Cancer Discovery
- Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
- (2015) Alice Cani et al. Oncotarget
- Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia
- (2015) Stefano Iacovelli et al. Oncotarget
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
- (2015) Alberto M. Martelli et al. Oncotarget
- Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation
- (2015) Carolina Simioni et al. Oncotarget
- Efficacy of dual PI-3K and mTOR inhibitors in vitro and in vivo in acute lymphoblastic leukemia
- (2015) Jacky Wong et al. Oncotarget
- mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells
- (2015) Brandon R. Beagle et al. Oncotarget
- Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
- (2014) J. Irving et al. BLOOD
- Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels
- (2014) A. M. Gomes et al. HAEMATOLOGICA
- Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)
- (2014) CAMILLA EVANGELISTI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis
- (2014) T. Hoshii et al. JOURNAL OF BIOCHEMISTRY
- Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
- (2014) C Reynolds et al. LEUKEMIA
- mTOR Inhibition by Everolimus in Childhood Acute Lymphoblastic Leukemia Induces Caspase-Independent Cell Death
- (2014) Rana Baraz et al. PLoS One
- Rictor Is Required for Early B Cell Development in Bone Marrow
- (2014) Yingchi Zhang et al. PLoS One
- Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis
- (2014) T Liu et al. Cell Death & Disease
- Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies
- (2014) Sarah K. Tasian et al. Frontiers in Oncology
- Efficacy of ponatinib against ABL tyrosine kinase inhibitor-resistant leukemia cells
- (2013) Seiichi Okabe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation
- (2013) Masahiro Morita et al. Cell Metabolism
- Targeting T cells to tumor cells using bispecific antibodies
- (2013) Stanley R Frankel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+acute lymphoblastic leukemia cells
- (2013) Xi Yang et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Regulation of mTORC1 and its impact on gene expression at a glance
- (2013) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential
- (2013) L M Neri et al. LEUKEMIA
- Novel targeted therapies in acute lymphoblastic leukemia
- (2013) Craig A. Portell et al. LEUKEMIA & LYMPHOMA
- Distinct sensitivity of CD8+CD4− and CD8+CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model
- (2013) Yingchi Zhang et al. LEUKEMIA RESEARCH
- Pancreatic tumours escape from translational control through 4E-BP1 loss
- (2013) Y Martineau et al. ONCOGENE
- Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)
- (2013) Karolina Nemes et al. PLoS One
- Inhibition of PI3K/mTOR Overcomes Nilotinib Resistance in BCR-ABL1 Positive Leukemia Cells through Translational Down-Regulation of MDM2
- (2013) Jie Ding et al. PLoS One
- Differential Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway in Acute Lymphoblastic Leukemia
- (2013) Susanne Badura et al. PLoS One
- Early Lymphoid Development and Microenvironmental Cues in B-cell Acute Lymphoblastic Leukemia
- (2012) Jessica Purizaca et al. ARCHIVES OF MEDICAL RESEARCH
- Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia
- (2012) S. L. Maude et al. BLOOD
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling
- (2012) D. A. Altomare et al. CURRENT MEDICINAL CHEMISTRY
- A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
- (2012) Carmine Settembre et al. EMBO JOURNAL
- An overview of the mTOR pathway as a target in cancer therapy
- (2012) Ryan D Gentzler et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cellular signaling of amino acids towards mTORC1 activation in impaired human leucine catabolism
- (2012) Sonja C. Schriever et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
- (2012) C Simioni et al. LEUKEMIA
- PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response
- (2012) C Shepherd et al. LEUKEMIA
- Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia
- (2012) M R Janes et al. LEUKEMIA
- RAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristine
- (2012) P O Saunders et al. ONCOGENE
- Signaling in Control of Cell Growth and Metabolism
- (2012) P. S. Ward et al. Cold Spring Harbor Perspectives in Biology
- Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review
- (2011) Denise M. Oliansky et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies
- (2011) M. Gupta et al. BLOOD
- Activation of mTORC2 by Association with the Ribosome
- (2011) Vittoria Zinzalla et al. CELL
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors
- (2011) Ana Batista et al. EXPERIMENTAL HEMATOLOGY
- Antileukaemia effect of rapamycin alone or in combination with daunorubicin on ph+ acute lymphoblastic leukaemia cell line
- (2011) Xi Yang et al. HEMATOLOGICAL ONCOLOGY
- mTORC2 Protein-mediated Protein Kinase B (Akt) Serine 473 Phosphorylation Is Not Required for Akt1 Activity in Human Platelets
- (2011) Samantha F. Moore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts
- (2011) G Fuka et al. LEUKEMIA
- Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR–ABL
- (2011) Amanda J. Redig et al. LEUKEMIA & LYMPHOMA
- BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
- (2011) Cihangir Duy et al. NATURE
- Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia
- (2011) Naoto Morishita et al. PEDIATRIC BLOOD & CANCER
- The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells
- (2011) Y Kuwatsuka et al. Blood Cancer Journal
- Perspectives on the role of mTORC2 in B lymphocyte development, immunity and tumorigenesis
- (2011) Adam S. Lazorchak et al. Protein & Cell
- Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production
- (2010) S. Zhang et al. BLOOD
- Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia
- (2010) Maddalena Paganin et al. BLOOD REVIEWS
- Significance of SGK1 in the regulation of neuronal function
- (2010) Florian Lang et al. JOURNAL OF PHYSIOLOGY-LONDON
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia
- (2010) Konstantinos J. Mavrakis et al. NATURE CELL BIOLOGY
- RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia
- (2009) Roman Crazzolara et al. Autophagy
- Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
- (2009) A H Beesley et al. BRITISH JOURNAL OF CANCER
- PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
- (2009) Lakshmi Srinivasan et al. CELL
- Molecular mechanisms of mTOR-mediated translational control
- (2009) Xiaoju Max Ma et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
- (2008) M. Case et al. CANCER RESEARCH
- Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
- (2008) Alfredo Toschi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
- (2008) Michael G. Kharas et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypersensitivity of Ph-positive lymphoid cell lines to rapamycin: Possible clinical application of mTOR inhibitor
- (2008) Chikara Hirase et al. LEUKEMIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now